合益素产品市场规模、份额及成长分析（依产品类型、成分、剂型、通路及地区划分）－2026-2033年产业预测

全球合益素产品市场规模预计在 2024 年达到 8.9 亿美元，从 2025 年的 9.612 亿美元成长到 2033 年的 17.7911 亿美元，在预测期（2026-2033 年）内复合年增长率为 8%。

由于消费者对旨在改善肠道健康和整体健康的机能性食品的需求不断增长，益生菌和益生元相结合的合益素产品全球市场正蓬勃发展。合益素产品利用双歧桿菌和乳酸桿菌等常见菌株以及菊糖和果寡糖（FOS）等益生元纤维，以提高益生菌的存活率并支持消化系统健康。这些产品不仅旨在增强免疫力和认知功能，还能促进活力和能量，进而降低非传染性疾病的风险。不断上涨的医疗保健成本正在推动对合益素的需求，尤其是在寻求儿童健康解决方案的家庭中。製造商正致力于产品差异化，并透过添加合益素来提高食品和饮料的营养价值。这一成长趋势反映了消费者越来越愿意投资于自身的健康和福祉。

推动全球合益素产品市场发展的因素

消费者对健康生活方式日益增长的偏好推动了功能性食品和饮料的需求，进而激发了开发中国家对合益素产品的兴趣。生活方式和饮食习惯的改变促使越来越多的人寻求营养补充剂，进一步提升了合益素产品的吸引力。益生元和益生菌在机能性食品中的日益普及也促进了市场扩张。这些合益素产品在维持健康的肠道环境、增强免疫力、活力和认知功能以及促进整体健康方面发挥关键作用。合益素产品透过促进消化、改善营养吸收、辅助体重管理以及帮助降低多种非传染性疾病的风险，以经济实惠的价格为消费者带来显着的健康益处。因此，食品和饮料生产商正越来越多地将这些有益成分添加到产品中，以增强其营养成分并满足消费者对健康的需求，从而推动了全球合益素产品市场的成长。

限制全球合益素产品市场的因素

由于製造成本不断上涨，全球合益素产品市场成长面临严峻挑战。该行业的生产商因关键原材料和劳动力短缺而面临产量限制。食品、饮料和製药业的生产和供应链中断也加剧了市场萎缩。此外，益生菌菌株的选择过程需要对安全性、功能性和技术功效进行全面评估，这增加了成本考量，影响了消费者和企业的购买力。这些因素共同阻碍了合益素市场的扩张潜力，并为生产者带来了复杂的局面。

合益素产品市场的全球趋势

全球合益素产品市场呈现稳定成长的趋势，这主要得益于消费者健康意识的提升和对机能性食品需求的增加。随着人们对肠道健康的日益关注，益生菌和益生元正成为食品和饮料配方中不可或缺的成分。益生元-益生菌组合产品的日益普及，因其单次服用即可获得双重益处，正推动着消费者兴趣的成长和市场的扩张。此外，消费者对膳食补充剂的偏好，尤其是那些采用先进递送技术（例如Licaps胶囊中胶囊）的产品，显示市场正致力于提升产品的功效和便利性。频繁的产品创新也进一步推动了市场成长，满足了消费者多样化的需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 客户和购买标准分析
• 贸易分析
• 原料分析

全球合益素产品市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 饮食
• 营养补充品
• 饲料
• 其他产品类型

全球合益素市场规模（依成分及复合年增长率划分）（2026-2033 年）

• 益生元
• 益生菌
• 其他成分

全球合益素市场规模（按剂型和复合年增长率划分）（2026-2033 年）

• 粉末
• 液体
• 胶囊/片剂
• 其他形式

全球合益素产品市场规模（依分销管道划分）及复合年增长率（2026-2033 年）

• 超级市场/大卖场
• 便利商店
• 在线的
• 其他分销管道

全球合益素产品市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Pfizer Inc.（United States）
• Danone SA（France）
• Yakult Honsha Co., Ltd.（Japan）
• United Natural Foods, Inc.（United States）
• Kerry Group plc（Ireland）
• Glanbia plc（Ireland）
• Koninklijke DSM NV（Netherlands）
• ADM（Archer-Daniels-Midland Company）（United States）
• Probi AB（Sweden）
• BioGaia AB（Sweden）
• Lallemand Inc.（Canada）
• Sabinsa Corporation（United States）
• Biomin GmbH（Austria）
• Probiotical SpA（Italy）
• Seed Health, Inc.（United States）
• Herbalife Nutrition Ltd.（United States）
• Catalent, Inc.（United States）
• Chobani, LLC（United States）
• Tata Chemicals Ltd.（India）

结论与建议

Global Synbiotic Product Market size was valued at USD 890 Million in 2024 and is poised to grow from USD 961.2 Million in 2025 to USD 1779.11 Million by 2033, growing at a CAGR of 8% during the forecast period (2026-2033).

The global market for synbiotic products, which combine probiotics and prebiotics, is thriving as consumers seek functional food supplements that enhance gut health and overall wellness. Synbiotics leverage popular strains like Bifidobacterium and Lactobacilli, alongside prebiotic fibers such as inulin and FOS, to improve probiotic viability and support digestive health. These products not only aim to bolster immunity and cognitive health but also promote energy and vitality, thereby reducing the risk of noncommunicable diseases. As healthcare spending rises, demand for synbiotics grows, particularly among families seeking health solutions for children. Manufacturers are increasingly focusing on product differentiation and fortifying food and beverages with synbiotics to enhance nutritional value. This growing market trend reflects consumers' willingness to invest in their health and well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Synbiotic Product market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Synbiotic Product Market Segments Analysis

Global Synbiotic Product Market is segmented by Product Type, Ingredients, Form, Distribution Channel and region. Based on Product Type, the market is segmented into Food & Beverages, Dietary Supplements, Animal Feed and Other Product Type. Based on Ingredients, the market is segmented into Prebiotics, Probiotics and Other Ingredients. Based on Form, the market is segmented into Powder, Liquid, Capsules/Tablets and Other Forms. Based on Distribution Channel, the market is segmented into Supermarkets/Hypermarkets, Convenience Stores, Online and Other Distribution Channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Synbiotic Product Market

The rising inclination towards healthier lifestyles among consumers has boosted the demand for functional foods and beverages, subsequently increasing interest in synbiotic products across both developed and developing regions. As lifestyle and dietary habits evolve, more individuals are seeking nutritional supplements, further propelling the appeal of synbiotic offerings. The growing incorporation of prebiotics and probiotics into functional foods supports market expansion. These synbiotic products play a crucial role in maintaining a healthy intestinal environment, enhancing immunity, energy, cognitive function, and overall vitality. By promoting better digestion, nutrient absorption, and weight management while reducing the risk of various noncommunicable diseases, synbiotic products offer significant health advantages, often justifying higher prices for consumers. As a result, food and beverage companies are increasingly fortifying their products with these beneficial ingredients to enhance nutritional profiles and cater to health-conscious demands, driving the growth of the global synbiotic products market.

Restraints in the Global Synbiotic Product Market

The growth of the global synbiotic product market faces significant challenges due to elevated manufacturing costs. Producers in this sector encounter limitations in output stemming from shortages of essential raw materials and workforce availability. Disruptions in production and supply chains within the food, beverage, and pharmaceutical industries further contribute to a decline in the market. Additionally, the selection process for probiotic strains requires a thorough evaluation of safety, functionality, and technological efficacy, which imposes financial considerations that affect both consumer and business affordability. These factors collectively hinder the expansion potential of the synbiotic market, creating a complex landscape for manufacturers.

Market Trends of the Global Synbiotic Product Market

The Global Synbiotic Product market is witnessing a robust trend fueled by the increasing health consciousness among consumers and a rising demand for functional foods. With the growing awareness around gut health, probiotics and prebiotics are becoming essential components in food and beverage formulations. The popularity of pre-pro combinations, which offer the convenience of dual benefits in a single dosage, is driving consumer interest and market expansion. Additionally, the preference for dietary supplements, particularly those utilizing advanced delivery technologies like Licaps capsule-in-a-capsule, illustrates the market's commitment to enhancing efficacy and convenience. Frequent product innovations are further propelling growth, meeting diverse consumer needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Synbiotic Product Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Food & Beverages
• Dietary Supplements
• Animal Feed
• Other Product Type

Global Synbiotic Product Market Size by Ingredients & CAGR (2026-2033)

• Market Overview
• Prebiotics
• Probiotics
• Other Ingredients

Global Synbiotic Product Market Size by Form & CAGR (2026-2033)

• Market Overview
• Powder
• Liquid
• Capsules/Tablets
• Other Forms

Global Synbiotic Product Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Supermarkets/Hypermarkets
• Convenience Stores
• Online
• Other Distribution Channels

Global Synbiotic Product Market Size & CAGR (2026-2033)

• North America (Product Type, Ingredients, Form, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Ingredients, Form, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Ingredients, Form, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Ingredients, Form, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Ingredients, Form, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danone S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yakult Honsha Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Natural Foods, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glanbia plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke DSM N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM (Archer-Daniels-Midland Company) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Probi AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGaia AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sabinsa Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomin GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Probiotical S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seed Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife Nutrition Ltd. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chobani, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tata Chemicals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations